CLOSE

Medstop AB

10 April 2013

Segulah IV L.P. has entered into an agreement to sell 100% of the shares in Medstop Group Holding AB to Oriola-KD Holding Sverige AB. The transaction is subject to the approvals of the Swedish Competition Authority (Konkurrensverket) and the Swedish Medical Products Agency (Läkemedelsverket). If and when the transaction closes, an Early Redemption Event will occcur according to the Terms & Conditions, which gives Medstop the right to redeem the notes and the Noteholders the option to request a redemption of the Notes. CorpNordic has a dialogue with Medstop and will keep the Noteholders informed.
For further information please contact Jolande Svensson-Klijn.

Our services

Corporate Client Services

Operating internationally can be challenging. You need a partner who understands local rules, culture and customs and how they affect legal and regulatory requirements. That’s where we come in.

Can't find what you're looking for?

View all corporate client services

Private Capital & Hedge Funds Services

We differentiate our global leading fund services through our geographical spread, domain strength, technology offering and depth of services.

Can't find what you're looking for?

View all private capital & hedge fund services

Capital Markets

As capital markets evolve across the globe, you need a bespoke approach from a service provider with a genuine understanding of how markets are changing.

Can't find what you're looking for?

View all capital markets services

Private Wealth

By understanding the importance of long-term relationships built around trust, we aim to truly understand your values. We’re your partner to help you protect, preserve and plan for the future.

Can't find what you're looking for?

View all private wealth services